StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.37−0.03 (-2.14%)

Close on Nov 18, 2026Market cap $87.31MP/E –Yield –

TuHURA Biosciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for TuHURA Biosciences

TuHURA Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More TuHURA Biosciences figures

See a number that looks wrong?